Voyager Therapeutics Inc (NASDAQ: VYGR) on Friday, plunged -9.32% from the previous trading day, before settling in for the closing price of $6.22. Within the past 52 weeks, VYGR’s price has moved between $5.71 and $11.72.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 355.29% annually for the last half of the decade. The company achieved an average annual earnings per share of -133.71%. With a float of $45.16 million, this company’s outstanding shares have now reached $54.63 million.
In an organization with 162 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 77.42%, operating margin of 5.54%, and the pretax margin is 16.35%.
Voyager Therapeutics Inc (VYGR) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Voyager Therapeutics Inc is 17.32%, while institutional ownership is 64.66%. The most recent insider transaction that took place on Oct 02 ’24, was worth 34,914. In this transaction Chief Legal Officer of this company sold 5,999 shares at a rate of $5.82, taking the stock ownership to the 86,001 shares. Before that another transaction happened on Oct 02 ’24, when Company’s Officer proposed sale 5,999 for $5.82, making the entire transaction worth $34,920.
Voyager Therapeutics Inc (VYGR) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -133.71% per share during the next fiscal year.
Voyager Therapeutics Inc (NASDAQ: VYGR) Trading Performance Indicators
Voyager Therapeutics Inc (VYGR) is currently performing well based on its current performance indicators. A quick ratio of 8.45 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.72, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.76 in one year’s time.
Technical Analysis of Voyager Therapeutics Inc (VYGR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.66 million. That was better than the volume of 0.64 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 11.36%. Additionally, its Average True Range was 0.48.
During the past 100 days, Voyager Therapeutics Inc’s (VYGR) raw stochastic average was set at 1.26%, which indicates a significant decrease from 2.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.79% in the past 14 days, which was lower than the 73.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.62, while its 200-day Moving Average is $7.81. However, in the short run, Voyager Therapeutics Inc’s stock first resistance to watch stands at $6.00. Second resistance stands at $6.35. The third major resistance level sits at $6.56. If the price goes on to break the first support level at $5.44, it is likely to go to the next support level at $5.23. Assuming the price breaks the second support level, the third support level stands at $4.88.
Voyager Therapeutics Inc (NASDAQ: VYGR) Key Stats
Market capitalization of the company is 279.36 million based on 54,626K outstanding shares. Right now, sales total 250,010 K and income totals 132,330 K. The company made 29,580 K in profit during its latest quarter, and -10,140 K in sales during its previous quarter.
